FDAAA Leadership

Director / Activities Cochair

Anne Marie Finley, JD

Anne Marie Finley

Anne Marie Finley is the President of Biotech Policy Group LLC, a healthcare government relations and regulatory policy consulting firm In the Washington DC area that she founded in 2001. Biotech Policy Group specializes in public policy representation of pharmaceutical, orphan drug, biologic, diagnostic and device clients.

In September 2013, she was named to the list of "Top 50 Thought-Leaders in Orphan Drugs and Rare Diseases" by the World Orphan Drug Congress as "an expert with access to different national regulators, Anne Marie has a unique holistic perspective on the challenges surrounding orphan drug development across multiple markets."

She was the Vice President, Government Relations and Public Policy at Celgene from 2007-2013 before returning to Biotech Policy Group. Previously, she held positions at GE Healthcare (formerly Amersham Health); Ketchum; US House of Representatives’ Committee on Government Reform and Oversight and Hershey Foods Corporation. She served in the administration of President George H.W. Bush as Special Assistant for Legislative and Public Affairs in the Office of the Commissioner, US Food and Drug Administration.

Anne Marie was appointed by the Secretary of Health and Human Services to the HHS Advisory Committee on Blood Safety and Availability and served from 2007-2011. She is a certified Regulatory Affairs specialist (RAC) and is the author of numerous reports and articles on orphan drugs, infectious agents, blood safety, food safety and food additives.

She is currently on the Board of Directors of the FDA Alumni Association and co-chaired its Activities Committee from 2003-2014. She was a trustee of the Hemophilia Association of New Jersey from 2005-2011.

She is a past president of Women in Government Relations and a former instructor in The Washington Representative Program, a graduate government relations program at The George Washington University.

Anne Marie received a BA in Government from Georgetown University and an MS in Science and Technology Commercialization from The University of Texas at Austin. She also earned a graduate certificate in government relations from The George Washington University.